ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,153Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 54

$1.76M Total Retail Price of All Prescriptions

Rank: 1 out of 54

616 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 29,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 1,996 1,863 1 1
FUROSEMIDE 1,311 1,252 2 3
AMLODIPINE BESYLATE 1,185 1,136 3 4
LISINOPRIL 1,184 1,147 4 6
LEVOTHYROXINE SODIUM 1,089 1,038 5 2
MIRTAZAPINE 1,079 1,050 6 11
METOPROLOL TARTRATE 944 901 7 7
TRAZODONE HCL 853 771 8 10
SIMVASTATIN 782 729 9 5
DONEPEZIL HCL 756 744 10 8
NAMENDA 618 618 11 13
OMEPRAZOLE 509 495 12 9
QUETIAPINE FUMARATE 447 407 13 21
CYMBALTA 447 401 13 26
GABAPENTIN 447 406 13 16
ESCITALOPRAM OXALATE 416 358 16 18
SERTRALINE HCL 414 375 17 12
RISPERIDONE 404 377 18 23
POTASSIUM CHLORIDE 338 317 19 22
POLYETHYLENE GLYCOL 3350 310 297 20 37
METOPROLOL SUCCINATE 303 301 21 14
CITALOPRAM HBR 300 300 22 17
TRAMADOL HCL 293 293 23 32
ATENOLOL 279 267 24 24
CARVEDILOL 274 273 25 36
METFORMIN HCL 267 238 26 19
ATORVASTATIN CALCIUM 246 227 27 15
LANTUS 245 219 28 30
DIOVAN 236 222 29 29
ADVAIR DISKUS 232 198 30 42
TAMSULOSIN HCL 230 229 31 25
DIGOXIN 225 225 32 40
IPRATROPIUM-ALBUTEROL 213 210 33 54
HYDROCHLOROTHIAZIDE 206 206 34 20
OLANZAPINE 204 134 35 43
PREDNISONE 196 194 36 34
SEROQUEL 194 171 37 56
CLOPIDOGREL 193 191 38 38
OXYBUTYNIN CHLORIDE ER 190 155 39 62
CARBIDOPA-LEVODOPA 190 190 39 49
LIDODERM 184 168 41 44
LEVOFLOXACIN 175 167 42 77
SPIRIVA 171 152 43 51
DIVALPROEX SODIUM 162 137 44 28
RAMIPRIL 158 158 45 91
DILTIAZEM 24HR CD 158 157 45 94
TRAVATAN Z 156 156 47 71
ALENDRONATE SODIUM 155 147 48 31
TIMOLOL MALEATE 154 144 49 106
SPIRONOLACTONE 148 143 50 63
FLUOXETINE HCL 148 133 50 67
FORTICAL 140 137 52 118
GLIPIZIDE 140 140 52 47
LATANOPROST 140 140 52 97
VENLAFAXINE HCL ER 138 120 55 74
LEVETIRACETAM 138 110 55 46
OXYCODONE HCL 132 107 S2 57 57
ISOSORBIDE MONONITRATE ER 128 117 58 41
PLAVIX 117 117 59 59
KLOR-CON M20 116 116 60 68
ABILIFY 115 99 61 80
BACLOFEN 114 87 62 75
DIVALPROEX SODIUM ER 108 63 63 113
BUPROPION HCL SR 104 104 64 114
LEXAPRO 103 86 65 60
CEPHALEXIN 101 91 66 79
GENERLAC 101 93 66 83
NOVOLOG 100 84 68 66
ZOLPIDEM TARTRATE 98 87 69 35
PRAVASTATIN SODIUM 98 88 69 27
BRIMONIDINE TARTRATE 98 98 69 131
ALLOPURINOL 98 80 69 52
PAROXETINE HCL 96 89 73 69
METOLAZONE 95 81 74 132
FINASTERIDE 95 94 74 73
MECLIZINE HCL 95 94 74 92
RANITIDINE HCL 93 92 77 50
RESTASIS 92 72 78 133
EXELON 91 82 79 63
HYDRALAZINE HCL 90 90 80 58
LAMOTRIGINE 89 80 81 101
TAMIFLU 88 86 82 110
LOSARTAN POTASSIUM 86 86 83 48
OLANZAPINE ODT 83 69 84 135
AZITHROMYCIN 83 78 84 65
HUMALOG 82 76 86 108
NEXIUM 79 50 87 45
FAMOTIDINE 79 71 87 55
FENTANYL 77 70 S2 89 92
ALBUTEROL SULFATE 73 68 90 84
SINGULAIR 70 66 91 99
BUPROPION HCL 69 69 92 143
GLYBURIDE 68 68 R 93 71
ZETIA 67 65 94 120
PHENYTOIN SODIUM EXTENDED 65 36 95 148
ROPINIROLE HCL 64 64 96 150
COLCRYS 64 64 96 110
PANTOPRAZOLE SODIUM 63 63 98 33
ENULOSE 63 58 98 151
CLOTRIMAZOLE 62 58 100 117
VALPROIC ACID 60 40 101 155
GLIMEPIRIDE 59 59 102 100
GEMFIBROZIL 58 58 103 160
CEFTRIAXONE 58 57 103 160
EVISTA 57 57 105 162
CLOTRIMAZOLE-BETAMETHASONE 56 47 106 85
METOCLOPRAMIDE HCL 56 56 106 105
NYSTATIN 56 54 106 164
GALANTAMINE HBR 56 56 106 164
NYSTOP 53 49 110 107
LIDOCAINE HCL 53 53 110 173
TOPIRAMATE 52 27 112 109
GLIPIZIDE ER 51 47 113 101
HUMULIN N 50 50 114 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.